檢索結果 - Francesco Merli
- Showing 1 - 20 results of 34
- Go to Next Page
-
1
-
2
Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients 由 Márcia Torresan Delamain, María Gomes da Silva, Eliana Miranda, Joana Desterro, Stefano Luminari, Anna Fedina, Francesco Merli, Carlos Chiattone, Kátia Bórgia Barbosa Pagnano, Massimo Federico, Cármino Antônio De Souza
出版 2016Artigo -
3
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio‐genomic s... 由 Rexhep Durmo, Benedetta Donati, Louis Rebaud, Anne‐Ségolène Cottereau, Alessia Ruffini, Maria Elena Nizzoli, Sabino Ciavarella, Maria Carmela Vegliante, Christophe Nioche, Michel Meignan, Francesco Merli, Annibale Versari, Alessia Ciarrocchi, Irène Buvat, Stefano Luminari
出版 2022Artigo -
4
ABVD Versus Modified Stanford V Versus MOPPEBVCAD With Optional and Limited Radiotherapy in Intermediate- and Advanced-Stage Hodgkin's Lymphoma: Final Results of a Multicenter Rand... 由 Paolo G. Gobbi, Alessandro Levis, Teodoro Chisesi, Chiara Broglia, Umberto Vitolo, Caterina Stelitano, Vincenzo Pavone, Luigi Cavanna, Gino Santini, Francesco Merli, Marina Liberati, Luca Baldini, Giorgio La Nasa, Emanuele Angelucci, Roberto Bordonaro, Massimo Federico
出版 2005Artigo -
5
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis 由 Francesca Palandri, Roberto Latagliata, Nicola Polverelli, Alessia Tieghi, Monica Crugnola, B. Martino, Margherita Perricone, Massimo Breccia, Emanuela Ottaviani, Nicoletta Testoni, Francesco Merli, Franco Aversa, Giuliana Alimena, Michèle Cavo, Giovanni Martinelli, Lucia Catani, Michele Baccarani, Nicola Vianelli
出版 2015Artigo -
6
The prognostic value of positron emission tomography performed after two courses (<scp>INTERIM‐PET</scp>) of standard therapy on treatment outcome in early stage <scp>H</scp>odgkin... 由 Luigi Rigacci, Benedetta Puccini, Pier Luigi Zinzani, Alberto Biggi, Antonio Castagnoli, Francesco Merli, Monica Balzarotti, Caterina Stelitano, Michele Spina, Umberto Vitolo, Vittorio Stefoni, Alessandro Levis, Manuel Gotti, Rosaria Sancetta, Stefani Piero Maria, Alberto Bosi, Andrea Gallamini
出版 2015Artigo -
7
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfo... 由 Massimo Federico, Stefano Luminari, Emilio Iannitto, Giuseppe Polimeno, Luigi Marcheselli, Antonella Montanini, Antonio La Sala, Francesco Merli, Caterina Stelitano, Samantha Pozzi, Renato Scalone, Nicola Di Renzo, Pellegrino Musto, Luca Baldini, Giulia Cervetti, F. Angrilli, Patrizio Mazza, Maura Brugiatelli, Paolo G. Gobbi
出版 2009Artigo -
8
Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractor... 由 Armando Santoro, Rita Mazza, Alessandro Pulsoni, Alessandro Re, Maurizio Bonfichi, Vittorio Ruggero Zilioli, Flavia Salvi, Francesco Merli, Antonella Anastasia, Stefano Luminari, Giorgia Annechini, Manuel Gotti, Annalisa Peli, Anna Marina Liberati, Nicola Di Renzo, Luca Castagna, Laura Giordano, Carmelo Carlo‐Stella
出版 2016Artigo -
9
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials 由 Matthew J. Maurer, Thomas M. Habermann, Qian Shi, Norbert Schmitz, David Cunningham, Michael Pfreundschuh, John F. Seymour, Ulrich Jaeger, Corinne Haïoun, Hervé Tilly, Hervé Ghesquières, Francesco Merli, Marita Ziepert, Raoul Herbrecht, Jocelyne Flament, Tommy Fu, Christopher R. Flowers, Bertrand Coiffier
出版 2018Artigo -
10
R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linf... 由 Massimo Federico, Stefano Luminari, Alessandra Dondi, Alessandra Tucci, Umberto Vitolo, Luigi Rigacci, Francesco Di Raimondo, Angelo Michele Carella, Alessandro Pulsoni, Francesco Merli, Luca Arcaini, F. Angrilli, Caterina Stelitano, Gianluca Gaïdano, Matteo Dell’Olio, Luigi Marcheselli, Vito Franco, Sara Galimberti, Stefano Sacchi, Maura Brugiatelli
出版 2013Artigo -
11
Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient–Level Analysis of Multiple Randomized Tri... 由 Qian Shi, Norbert Schmitz, Fang‐Shu Ou, Jesse G. Dixon, David Cunningham, Michael Pfreundschuh, John F. Seymour, Ulrich Jaeger, Thomas M. Habermann, Corinne Haïoun, Hervé Tilly, Hervé Ghesquières, Francesco Merli, Marita Ziepert, Raoul Herbrecht, Jocelyne Flament, Tommy Fu, Bertrand Coiffier, Christopher R. Flowers
出版 2018Artigo -
12
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma 由 Luca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, Andrés J.M. Ferreri, Barbara Botto, Caterina Stelitano, Manuel Gotti, Maria Giuseppina Cabras, Luigi Rigacci, Livio Gargantini, Francesco Merli, Graziella Pinotti, Donato Mannina, Stefano Luminari, Anastasios Stathis, Eleonora Russo, Franco Cavalli, Luca Giovanella, Peter Johnson, Emanuele Zucca
出版 2015Artigo -
13
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi 由 Stefano Luminari, Irène Biasoli, Luca Arcaini, Annibale Versari, C. Rusconi, Francesco Merli, Michele Spina, Andrés J.M. Ferreri, Pier Luigi Zinzani, Andrea Gallamini, Sonia Mastronardi, Carola Boccomini, Gianluca Gaïdano, Alfonso Maria D’Arco, Francesco Di Raimondo, Angelo Michele Carella, Armando Santoro, Pellegrino Musto, Massimo Federico
出版 2013Artigo -
14
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL) 由 Stefano Luminari, Irène Biasoli, Annibale Versari, Sara Rattotti, Chiara Bottelli, C. Rusconi, Francesco Merli, Michele Spina, Andrés J.M. Ferreri, Pier Luigi Zinzani, Andrea Gallamini, Antonella Franceschetto, Carola Boccomini, Silvia Franceschetti, Flavia Salvi, Francesco Di Raimondo, A Carella, Micol Quaresima, Monica Balzarotti, Pellegrino Musto, Massimo Federico
出版 2014Artigo -
15
First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an Internatio... 由 Umberto Vitolo, Annalisa Chiappella, Andrés J.M. Ferreri, Maurizio Martelli, Ileana Baldi, Monica Balzarotti, Chiara Bottelli, Annarita Conconi, Henry Gómez, Armando López‐Guillermo, Giovanni Martinelli, Francesco Merli, Domenico Novero, Lorella Orsucci, Vincenzo Pavone, Umberto Ricardi, Sergio Storti, Mary Gospodarowicz, Franco Cavalli, Andreas H. Sarris, Emanuele Zucca
出版 2011Artigo -
16
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients 由 Nicola Polverelli, Massimo Breccia, Giulia Benevolo, Bruno Martino, Alessia Tieghi, Roberto Latagliata, Elena Sabattini, Mara Riminucci, Laura Godio, Lucia Catani, Maura Nicolosi, Margherita Perricone, Daria Sollazzo, Gioia Colafigli, Anna Maria Campana, Francesco Merli, Umberto Vitolo, Giuliana Alimena, Giovanni Martinelli, Russell E. Lewis, Nicola Vianelli, Michèle Cavo, Francesca Palandri
出版 2016Artigo -
17
Prognostic Role of Revised International Prognostic Score for Waldenstrom Macroglobulinemia (rIPSSWM) in Newly Diagnosed Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma: A... 由 Angela Ferrari, Sara Rattotti, Simone Ferrero, Michele Merli, Francesco Merli, Sara Veronica Usai, Marina Deodato, Alessandro Pulsoni, Emanuele Cencini, Francesca Re, Maria Chiara Tisi, Márcia Torresan Delamain, Michele Spina, Ombretta Annibali, Angela Rago, Carola Boccomini, Andrés J.M. Ferreri, Maria Elena Nizzoli, Luca Arcaini, Stefano Luminari, Marzia Varettoni
出版 2022Artigo -
18
Development of a Novel Prognostic Score in Patients with Waldenström Macroglobulinemia Prospectively Enrolled in the Observational NF10 Study of Fondazione Italiana Linfomi 由 Marzia Varettoni, Angela Ferrari, Luigi Marcheselli, Michele Merli, Sara Rattotti, Simone Ferrero, Francesco Merli, Sara Veronica Usai, Marina Deodato, Alessandro Pulsoni, Emanuele Cencini, Francesca Re, Carlo Visco, Márcia Torresan Delamain, Michele Spina, Ombretta Annibali, Angela Rago, Carola Boccomini, Andrés J.M. Ferreri, Maria Elena Nizzoli, Luca Arcaini, Stefano Luminari
出版 2023Artigo -
19
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma 由 Stefano Luminari, Angela Ferrari, Martina Manni, Alessandra Dondi, Annalisa Chiarenza, Francesco Merli, Chiara Rusconi, Vittoria Tarantino, Alessandra Tucci, Umberto Vitolo, Sofya Kovalchuk, Emanuele Angelucci, Alessandro Pulsoni, Luca Arcaini, F. Angrilli, Gianluca Gaïdano, Caterina Stelitano, Giovanni Bertoldero, Nicola Cascavilla, Flavia Salvi, Andrés J.M. Ferreri, Daniele Vallisa, Luigi Marcheselli, Massimo Federico
出版 2017Artigo -
20
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>... 由 Sergio Storti, Michele Spina, Emanuela Anna Pesce, Flavia Salvi, Michele Merli, Alessia Ruffini, Giuseppina Cabras, Annalisa Chiappella, Emanuele Angelucci, Alberto Fabbri, Anna Marina Liberati, Monica Tani, Gerardo Musuraca, Annalia Molinari, Maria Pia Petrilli, Carmela Palladino, Rosanna Ciancia, Andrea Ferrario, Cristiana Gasbarrino, Federico Monaco, Vincenzo Fraticelli, Annalisa De Vellis, Francesco Merli, Stefano Luminari
出版 2018Artigo
相關主題
Internal medicine
Medicine
Lymphoma
Oncology
Chemotherapy
Confidence interval
Gastroenterology
Cyclophosphamide
Hazard ratio
Rituximab
Vincristine
Surgery
Biology
Nuclear medicine
Clinical trial
Follicular lymphoma
Randomized controlled trial
ABVD
Diffuse large B-cell lymphoma
Positron emission tomography
Bendamustine
Clinical endpoint
Dacarbazine
Immunology
Neutropenia
Paleontology
Progression-free survival
Proportional hazards model
Radiology
Retrospective cohort study